BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 86175)

  • 1. [Role of alpha 1-antitrypsin and alpha-2 macroglobulin in hepatopathies].
    Triolo L; Mian G; Magris D; Novello E; D'Agnolo B
    Minerva Med; 1979 Feb; 70(8):605-10. PubMed ID: 86175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum protease inhibitors in opisthorchiasis, hepatoma, cholangiocarcinoma, and other liver diseases.
    Changbumrung S; Migasena P; Supawan V; Juttijudata P; Buavatana T
    Southeast Asian J Trop Med Public Health; 1988 Jun; 19(2):299-305. PubMed ID: 2465579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum concentration of alpha 1-antitrypsin in various hepatic diseases].
    Villamil F; Galli B; Sorroche P; Occello M; Gelpi J; Welz G
    Medicina (B Aires); 1986; 46(2):139-42. PubMed ID: 3033426
    [No Abstract]   [Full Text] [Related]  

  • 4. [Alpha 1-antitrypsin and neoplasms].
    Millán Núñez-Cortés J
    Rev Clin Esp; 1984 Aug 15-31; 174(3-4):65-7. PubMed ID: 6083585
    [No Abstract]   [Full Text] [Related]  

  • 5. The serum protein profile in chronic hepatitis, cirrhosis and liver cancer.
    Hiramatsu S; Kojima J; Okada TT; Inai S; Ohmori K
    Acta Hepatogastroenterol (Stuttg); 1976 Jun; 23(3):177-82. PubMed ID: 60035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alpha-fetoprotein in relation to the age of the subject. Normal and pathological levels].
    Hurjui J; Teodorovici I; Creţeanu M
    Rev Med Chir Soc Med Nat Iasi; 1980; 84(2):283-6. PubMed ID: 6164085
    [No Abstract]   [Full Text] [Related]  

  • 7. Hepatocyte growth factor and acute phase proteins in patients with chronic liver diseases.
    Shiota G; Umeki K; Okano J; Kawasaki H
    J Med; 1995; 26(5-6):295-308. PubMed ID: 8721905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Behavior of serum alpha 1-antitrypsin in chronic hepatopathies and its diagnostic significance].
    Tartaglino B; Macrì G; Molino G; Furlani D; Sansalvadore F
    Quad Sclavo Diagn; 1980 Dec; 16(4):451-8. PubMed ID: 6166021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Alpha 1 antitrypsin in cryptogenetic cirrhosis (author's transl)].
    Plaitano G; Guardascione F; Politi C
    Quad Sclavo Diagn; 1979 Jun; 15(2):165-9. PubMed ID: 317972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum calcitonin levels in hepatocellular carcinoma and other liver diseases.
    Fujiyama S; Sagara K; Sato T
    Horm Metab Res; 1986 Jun; 18(6):421-2. PubMed ID: 3015758
    [No Abstract]   [Full Text] [Related]  

  • 11. Alpha-1-antitrypsin deficiency and liver diseases in Nigeria.
    Olusi SO
    Trop Geogr Med; 1990 Jan; 42(1):41-6. PubMed ID: 2175465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of a method of combined determination of the activity of the trypsin-like proteinases, alpha 1-antitrypsin and alpha 2-macroglobulin, in a gastroenterology clinic].
    Kariagina IIu; Zarembskiĭ RA; Baliabina MD
    Lab Delo; 1990; (2):10-3. PubMed ID: 1692355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial changes in serum alpha-fetoprotein prior to detection of hepatocellular carcinoma in liver cirrhosis.
    Kuwahara T; Sakai T; Majima Y; Hirai K; Tanikawa K
    Hepatogastroenterology; 1993 Aug; 40(4):347-51. PubMed ID: 7691701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum alpha-1-antitrypsin and alpha-1-antichymotrypsin in the diagnosis of primary hepatocellular carcinoma.
    Xu KC; Wei Q; Meng XY
    Chin Med J (Engl); 1989 Nov; 102(11):834-8. PubMed ID: 2561553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Behavior of alpha 1-antitrypsin and alpha 2-macroglobulin in hepatic cirrhosis].
    Amiguet JA; Bueno J; Barrao F; Giménez A; Liso P
    Rev Esp Enferm Apar Dig; 1985 Dec; 68(6):506-10. PubMed ID: 2419949
    [No Abstract]   [Full Text] [Related]  

  • 16. Is there a relationship between alpha-1-antitrypsin Pi MZ phenotype and hepatoma?
    Charlionet R; Martin JP; Sesboué R; Ropartz C
    Biomedicine; 1976 Jun; 25(4):125-6. PubMed ID: 60146
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum trypsin inhibitory capacity and alpha 1-antitrypsin levels in liver cirrhosis and hepatoma.
    Theodoropoulos G; Archimandritis A; Tsomi A; Chloros G; Rigatos G; Angelopoulos B
    Acta Hepatogastroenterol (Stuttg); 1979 Jun; 26(3):195-7. PubMed ID: 225915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha 1-antitrypsin phenotypes in cirrhosis and hepatoma.
    Theodoropoulos G; Fertakis A; Archimandritis A; Kapordelis C; Angelopoulos B
    Acta Hepatogastroenterol (Stuttg); 1976 Apr; 23(2):114-7. PubMed ID: 179260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Alpha 1-antitrypsin deficiency and the liver (author's transl)].
    Spech HJ; Liehr H
    Z Gastroenterol; 1982 Jul; 20(7):393-404. PubMed ID: 6287750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does the concentration of alpha 1-proteinase inhibitor reflect the transformation of liver cirrhosis to liver carcinoma?
    Dabrowska M; Mantur M; Panasiuk A; Prokopowicz J
    Neoplasma; 1997; 44(5):305-7. PubMed ID: 9473790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.